Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model (Q42481553)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 August 2015
edit
Language Label Description Also known as
English
Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model
scientific article published on 26 August 2015

    Statements

    Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model (English)
    Michael D Curley
    Lucia Wille
    Bambang S Adiwijaya
    Gabriela Garcia
    Victor Moyo
    Armina A Kazi
    Angela Brodie
    Gavin MacBeath
    26 August 2015
    2642-2652

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit